US Patent Issued to Gracell Biotechnologies (Shanghai), Suzhou Gracell Biotechnologies on Oct. 28 for "Compositions and methods for T cell engineering" (Chinese Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,454,564, issued on Oct. 28, was assigned to Gracell Biotechnologies (Shanghai) Co. Ltd. (Shanghai) and Suzhou Gracell Biotechnologies Co. Ltd. (Jiangsu, China).

"Compositions and methods for T cell engineering" was invented by Xinxin Wang (Shanghai), Tao Jin (Shanghai), Chunhui Yang (Shanghai), Zhongdong Shi (Shanghai), Liping Liu (Shanghai), Jing Sun (Shanghai), Shuyi Qiu (Shanghai) and Wei Cao (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to an engineered immune cell and use thereof. The present disclosure provides an engineered immune cell comprising a CAR or engineered TCR, which CAR or engineered TCR can co...